Board upheaval at 23andMe as all independent directors exit over CEO's privatisation plan
The resignations mark the latest challenge for the genetic-testing company after it struggled to find a profitable business model and was hit with a class-action lawsuit over a data breach
19 Sep 21:53 · The Mirror